Regular Article
Survivin expression in human osteosarcoma is a marker for survival

https://doi.org/10.1053/ejso.2002.1415Get rights and content

Abstract

Aims: Osteosarcoma is the most frequent malignant bone tumor with a peak incidence in the second and third decade of life. Evaluation of prognosis of patients with osteosarcoma is limited to clinical parameters whereas molecular markers of tumor aggression have not yet been identified. Inhibition of apoptotic cell death could play a role in the development or progression of neoplasia. Survivin is a member of the inhibitor of apoptosis (IAP) protein gene family and is expressed both during normal fetal development and in human cancer.

Methods: The localization and distribution of survivin was investigated immunohistochemically in high-grade osteosarcomas by an indirect immunoperoxidase method.

Results: Survivin was detected in the cytoplasm in 23/40 and in the nucleus in 20/40 cases of osteosarcoma. Nuclear localization of survivin expression was significantly correlated with a prolonged survival (P=0.0347) but cytoplasmic staining showed no correlation with patient outcome.

Conclusions: The results of this study indicates that the evaluation of survivin expression might be a useful prognostic marker in osteosarcoma. Patients with osteosarcoma exhibiting nuclear survivin expression could potentially benefit from stratification of neoadjuvant chemotherapy.

References (11)

  • E Okada

    Murai Y, Matsui K. Survivin expression in tumor cells nuclei is predictive of a favorable prognosis in gastric cancer patients

    Cancer Res

    (2001)
  • B Bieling et al.

    Tumor size and prognosis in aggressively treated osteosarcoma

    J Clin Oncol

    (1996)
  • G Ambrosini et al.

    A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

    Nat Med

    (1997)
  • CD Lu et al.

    Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas

    Cancer Res

    (1998)
  • M Kappler et al.

    Increased survivin transcript levels: an independent negative predictor of survival in soft tissue sarcoma patients

    Int J Cancer

    (2001)
There are more references available in the full text version of this article.

Cited by (114)

  • Immunohistochemical Validation of Spontaneously Arising Canine Osteosarcoma as a Model for Human Osteosarcoma

    2017, Journal of Comparative Pathology
    Citation Excerpt :

    Detection of specific tumour markers in OS is important for accurate diagnosis, prediction of prognosis, metastases and response to chemotherapy (Selvarajah and Kirpensteijn, 2010). Despite the aetiology of OS being complex, some tumour markers are expressed at low levels or are overexpressed in canine and human OS (Trieb et al., 2003; Barger et al., 2005; Won et al., 2009). Tumour markers that are generally expressed in human OS include vimentin, S100, osteonectin, osteocalcin, smooth muscle actin (SMA), CD99 and neuron-specific enolase (NSE) (Trihia and Valavanis, 2012).

  • A sandwich-type DNA biosensor based on electrochemical co-reduction synthesis of graphene-three dimensional nanostructure gold nanocomposite films

    2013, Analytica Chimica Acta
    Citation Excerpt :

    It has been considered to be an important factor that provides potent resistance against chemotherapeutic drugs [39]. Recent studies have demonstrated that survivin is correlated with osteosarcoma and could be used as a molecular marker for prognosis of osteosarcoma [40,41]. The reported techniques for gene detection included flow cytometry (FCM) [42], fluorescence in situ hybridization (FISH) [43], chromosome analysis [44], real-time quantitative reverse transcription polymerase chain reaction (RT-PCR) [45].

View all citing articles on Scopus
f1

Correspondence to: Prof. Dr Klemens Trieb, Department of Orthopaedics, University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria. Tel: +43-1-40400-4070; Fax: +43-1-40400-4077; E-mail:[email protected]

View full text